Your weekly roundup of the latest biotech research and innovation.
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 97 | Founded | 2 years ago | Last Issue | 11 days ago |
| Active | |||||
Read this Newsletter
biotechdodo.comLatest Issues
#96 - Pathology platforms, pumped-up funding rounds & pelagic collagen
Hello, my fellow seafarers,
This week has been anything but calm waters: Isomorphic Labs is going full steam ahead on one of the largest funding rounds in biotech history, Roche dropped a quarter‑billion dollar bounty on an AI pathology de...
#95 - Plasma peanuts, Pfizer's pitfalls & Pacific production
Hello, my fellow allergy sufferers,
With pollen counts rising and allergy season well underway, this week’s news arrives just in time: Pfizer has had a nasty reaction to its CD47 bet, Big Pharma gets a whiff of Asia’s ageing wave, Switzerl...
#94 - Bug biosecurity, brain chips and eye-boosting botanicals
Hello, my entomology enthusiasts,
This week, it’s a bug’s life as a creepy-crawly quarantine facility lands in York to shore up the UK’s biosecurity, saffron makes the leap from spice rack to retinal protection, Chiesi stings the US rare d...
#93 - Rosalind returns, repurposed rejects & rebel replication
Hello my fellow mavericks,
This week: Boehringer breaks ranks and builds its AI capabilities rather than buying them, OpenAI debuts a drug discovery model named after the woman who never got the credit she deserved, a Finnish startup defie...
#92 - Problematic proteins, AI sovereignty & predictive pregnancy puking
Hello, my nauseous friends,
This week’s roundup has plenty to digest: scientists are taking on “undruggable” disease proteins, pharma backs away from big biotech deals as patent cliffs loom, the UK launches a sovereign AI fund to anchor ho...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Biotech Dodo.
| Subscribers | Engagement | 67 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
Communications and community for healthtech and biotech.
Biotech Dodo Editor-in-Chief
Squawk
Pigeon friend
Frequently Asked Questions
How can I access the email archive for Biotech Dodo?
You can find recent issues that have been published by Biotech Dodo on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Biotech Dodo have?
To see how many people subscribe to Biotech Dodo, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Biotech Dodo?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Biotech Dodo as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Biotech Dodo?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Biotech Dodo using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Biotech Dodo?
Scroll up to where it says Related Newsletters to see other publications like Biotech Dodo. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Biotech Dodo?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.